Information letter on Thyrogen® (thyrotropin alfa): Supply shortage due to a manufacturing issue and temporary treatment recommendations from the EMA
2011.04.11
Active substance: thyrotropin alfa
An Rote-Hand-Brief on the treatment recommendations has been sent to attending physicians and pharmacies concerned.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN